Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B)

K-Number: K171404 · 2017-07-17

Decision Date2017-07-17
Product CodeHQD
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B) is a medical device manufactured by Bausch + Lomb, Incorporated. It received FDA 510(k) clearance on 2017-07-17 under approval number K171404. The device is classified under product code HQD. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B)?

BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B) is a medical device that received FDA 510(k) clearance on 2017-07-17. It is manufactured by Bausch + Lomb, Incorporated. The 510(k) number is K171404.

When was BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B) approved by the FDA?

BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B) received FDA 510(k) clearance on 2017-07-17, under approval number K171404.

What company makes BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B)?

BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B) is manufactured by Bausch + Lomb, Incorporated.

What is the FDA product code for BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B)?

The FDA product code for BOSTON XO (hexafocon A), BOSTON XO2 (hexafocon B) is HQD.

Other Devices by Bausch + Lomb, Incorporated

Related Devices (Code: HQD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.